Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study
Winer, Eric S., Safran, Howard, Karaszewska, Boguslawa, Bauer, Sebastian, Khan, Dilawar, Doerfel, Steffen, Burgess, Paul, Kalambakas, Stacey, Mostafa Kamel, Yasser, Forget, Frederic
Published in International journal of hematology (01.12.2017)
Published in International journal of hematology (01.12.2017)
Get full text
Journal Article
Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I study
Winer, Eric S., Safran, Howard, Karaszewska, Boguslawa, Richards, Donald A., Hartner, Lee, Forget, Frederic, Ramlau, Rodryg, Kumar, Kirushna, Mayer, Bhabita, Johnson, Brendan M., Messam, Conrad A., Mostafa Kamel, Yasser
Published in Cancer medicine (Malden, MA) (01.01.2015)
Published in Cancer medicine (Malden, MA) (01.01.2015)
Get full text
Journal Article
Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study
Winer, Eric S., Safran, Howard, Karaszewska, Boguslawa, Richards, Donald A., Hartner, Lee, Forget, Frederic, Ramlau, Rodryg, Kumar, Kirushna, Mayer, Bhabita, Johnson, Brendan Mark, Messam, Conrad A., Mostafa Kamel, Yasser Mostafa
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
Erba, Harry P, Montesinos, Pau, Kim, Hee-Je, Patkowska, Elżbieta, Vrhovac, Radovan, Žák, Pavel, Wang, Po-Nan, Mitov, Tsvetomir, Hanyok, James, Kamel, Yasser Mostafa, Rohrbach, Jaime E Connolly, Liu, Li, Benzohra, Aziz, Lesegretain, Arnaud, Cortes, Jorge, Perl, Alexander E, Sekeres, Mikkael A, Dombret, Hervé, Amadori, Sergio, Wang, Jianxiang, Levis, Mark J, Schlenk, Richard F
Published in The Lancet (British edition) (13.05.2023)
Published in The Lancet (British edition) (13.05.2023)
Get full text
Journal Article
Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors
El-Hariry, Iman, Mostafa Kamel, Yasser, Liu, Yuan, Martin, Anne-Marie, Messam, Conrad, Erickson-Miller, Connie L., Pandite, Lini, Baker, Katherine, Pillarisetti, Kodandaram, Chadderton, Antony, Gibbard, Anna, Kirchner, Jennifer
Published in Journal of oncology (01.01.2010)
Published in Journal of oncology (01.01.2010)
Get full text
Journal Article
P483: QUANTUM‐FIRST TRIAL: FLT3‐ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL
Levis, Mark J, Erba, Harry P., Montesinos, Pau, Vrhovac, Radovan, Patkowska, Elżbieta, Kim, Hee‐Je, Zak, Pavel, Wang, Po‐Nan, Connolly Rohrbach, Jaime E., Chang, Ken C.N., Hanyok, James, Liu, LI, Mostafa Kamel, Yasser, Lesegretain, Arnaud, Cortes, Jorge, Sekeres, Mikkael A., Dombret, Hervé, Amadori, Sergio, Wang, Jianxiang, Schlenk, Richard F., Perl, Alexander E.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
S137: IMPACT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION PLUS FLT3 INHIBITION WITH QUIZARTINIB IN ACUTE MYELOID LEUKEMIA WITH FLT3‐ITD: RESULTS FROM QUANTUM‐FIRST
Schlenk, Richard, Montesinos, Pau, Romero‐Aguilar, Antonio, Vrhovac, Radovan, Patkowska, Elżbieta, Kim, Hee‐Je, Zak, Pavel, Wang, Po‐Nan, Hanyok, James, Liu, LI, Kamel, Yasser Mostafa, Benzohra, Aziz, Lesegretain, Arnaud, Cortes, Jorge, Sekeres, Mikkael A., Dombret, Hervé, Amadori, Sergio, Wang, Jianxiang, Perl, Alexander E., Levis, Mark J., Erba, Harry P.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
Chawla, Sant P, Staddon, Arthur, Hendifar, Andrew, Messam, Conrad A, Patwardhan, Rita, Kamel, Yasser Mostafa
Published in BMC cancer (16.03.2013)
Published in BMC cancer (16.03.2013)
Get full text
Journal Article
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors
Erickson-Miller, Connie L, Pillarisetti, Kodandaram, Kirchner, Jennifer, Figueroa, David J, Ottesen, Lone, Martin, Anne-Marie, Liu, Yuan, Kamel, Yasser Mostafa, Messam, Conrad
Published in BMC cancer (11.09.2012)
Published in BMC cancer (11.09.2012)
Get full text
Journal Article
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects
Tosi, Sabrina, Mostafa Kamel, Yasser, Owoka, Temitayo, Federico, Concetta, Truong, Tony H, Saccone, Salvatore
Published in Biomarker research (05.10.2015)
Published in Biomarker research (05.10.2015)
Get full text
Journal Article
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes
Dharmani, Charles, Wang, Eric, Tu, Nora, Fofah, Oluwatosin, Cueto, Jenilee, Salas, Maribel, Kamel, Yasser Mostafa
Published in Future oncology (London, England) (01.08.2023)
Published in Future oncology (London, England) (01.08.2023)
Get full text
Journal Article
Quantum-First: Safety By Treatment Phase and By Age in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD) Positive Acute Myeloid Leukemia (AML)
Erba, Harry P., Dombret, Herve, Perl, Alexander, Mitov, Tsvetomir, Liu, Li, Kamel, Yasser Mostafa, Imadalou, Karima, Choi, Youngsook, Levis, Mark J., Schlenk, Richard F
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Kinetics of Complete Remission (CR) and CR Duration and Its Impact on Overall Survival (OS) and Event-Free Survival (EFS) in Quantum-First
Montesinos, Pau, Perl, Alexander, Sekeres, Mikkael A., Liu, Li, Kamel, Yasser Mostafa, Imadalou, Karima, Schlenk, Richard F, Erba, Harry P., Dombret, Hervé
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database
Dharmani, Charles, Wang, Eric, Tu, Nora, Salas, Maribel, Kamel, Yasser Mostafa
Published in Future oncology (London, England) (01.01.2023)
Published in Future oncology (London, England) (01.01.2023)
Get full text
Journal Article
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiologyand End Results-Medicare database
Dharmani, Charles, Wang, Eric, Tu, Nora, Salas, Maribel, Kamel, Yasser Mostafa
Published in Future oncology (London, England) (01.01.2023)
Published in Future oncology (London, England) (01.01.2023)
Get full text
Journal Article
Quantum-First (Q-F): Clinical Bridging Study for FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD) Companion Diagnostic Development
Rohrbach, Jaime E, Chang, Ken C N, Karnoub, Maha, Liu, Li, Kamel, Yasser Mostafa, Khambata-Ford, Shirin, Rivera, Shawn, Lameh, Jelveh, Rudenko, Ekaterina, Thornes, Jordan, Todt, Sarah, Gerhold, Jason, Huang, Ying, Miller, Jeffrey E, Perl, Alexander, Levis, Mark J., Ito, Kazumi
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction (IND) and Consolidation (CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3 -ITD+ AML Patients (pts)
Perl, Alexander, Erba, Harry P., Montesinos, Pau, Vrhovac, Radovan, Patkowska, Elzbieta, Kim, Heeje, Zak, Pavel, Wang, Po-Nan, Rohrbach, Jaime E, Chang, Ken C N, Liu, Li, Kamel, Yasser Mostafa, Imadalou, Karima, Lesegretain, Arnaud, Cortes, Jorge, Sekeres, Mikkael A., Dombret, Hervé, Amadori, Sergio, Wang, Jianxiang, Schlenk, Richard F, Levis, Mark J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article